Sign in

Booster dose not the focus of vaccination drive: Govt

A “booster dose” refers to an additional dose of the vaccine that is given to someone who has already built enough protection after being fully vaccinated.

Published on: Sep 17, 2021, 02:08:43 IST
By , Hindustan Times, New Delhi
Share
Share via
  • facebook
  • twitter
  • linkedin
Copy link
  • copy link

As discussion around the administration of booster shots of Covid-19 vaccines gathers momentum across the world, India on Thursday said that, as things stand, offering third doses of the vaccine was not the central focus of any government discussion on the country’s inoculation programme.

People get vaccinated against Covid-19 in Mumbai .  (HT PHOTO)
People get vaccinated against Covid-19 in Mumbai .  (HT PHOTO)

The priority, they said, was universal inoculation for the Indian population, which the government aims to achieve by the end of the year though it is running behind in terms of the daily jab rate despite an uptick in the past few weeks.

“[Administering] booster doses is not the central theme at the moment in the government’s scientific and public health care discussions... getting fully vaccinated with two doses remains the major priority,” said Dr Balram Bhargava, director general, Indian Council of Medical Research (ICMR), during the Union health ministry briefing on Covid-19 on Thursday.

A “booster dose” refers to an additional dose of the vaccine that is given to someone who has already built enough protection after being fully vaccinated. Since a majority of Covid-19 jabs are two-dose vaccines, booster dose in this context refers to a third shot. Health experts in countries such the US are currently engaged in a debate over whether booster doses are needed for healthy adults and whether they should be given out once the entire population is fully vaccinated. This is an important debate as it can mean that despite being fully vaccinated, rich countries may consume even more doses as several poorer nations of the world remain largely unvaccinated.

Experts agreed that it crucial for India to first fully vaccinate all eligible population before considering booster shots for those who have already received both doses. “What is important is to vaccinate all adults first as per plan. Booster doses can be thought about later. That is not our immediate requirement; however, it may be needed eventually,” said Dr GC Khilnani, former head, pulmonary and sleep medicine department, All India Institute of Medical Sciences, Delhi.

As for low antibody levels found in some people according to recent studies, Bharagava said that several agencies have recommended that antibody levels should not be the sole determinant of immunity against Covid-19. The study, published in the Research Square pre-print, of 614 fully vaccinated health workers in India found a significant drop in their Covid-fighting antibodies within four months of the first shot.

During the briefing, health officials also called a recent article by the New York Times on India’s Covid response a “provocative, attention-seeking” piece that came at a time when the country is doing well in handling the pandemic.

The NYT article said that ICMR tailored its findings to fit Prime Minister Narendra Modi’s optimistic narrative despite a looming crisis. “We greatly value journalistic and editorial freedom and at the same time we must also realise that all of us -- Union government as well as the state governments -- are fully emerged in fighting a pandemic and all our energies and time is devoted to that,” said Rajesh Bhushan, Union secretary for health and family welfare.

The ICMR chief added: “This is a provocative, attention seeking article published at a time when India is doing good and our vaccination is excellent and it is diverting attention.”

On the question of including children under the national Covid-19 immunisation programme, government officials said that the matter was still being deliberated upon.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More